🇺🇸 FDA
Patent

US 8937060

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

granted A61KA61K31/437A61K31/438

Quick answer

US patent 8937060 (1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders) held by Addex Pharma, S.A. expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/437, A61K31/438, A61K31/4545, A61K31/496